Amarin | AMRN - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amarin USD 48.15M 2.8M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
DBV Technologies USD 39.82M 972K 2025-09
Esperion Therapeutics USD 65.07M 12.44M 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03